CRISPR Breakthroughs Offer Hope for Down Syndrome and Genetic Disorders Treatment
A groundbreaking gene therapy from Regeneron Pharmaceuticals restored hearing in 80% of deaf children, including a 18-month-old patient who can now he...
A groundbreaking gene therapy from Regeneron Pharmaceuticals restored hearing in 80% of deaf children, including a 18-month-old patient who can now he...
President Trump finalized a drug-pricing agreement with Regeneron Pharmaceuticals, completing the last of 17 deals sought by the White House. Meanwhil...